Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Final Results

30th Jun 2009 07:00

RNS Number : 7464U
SerVision plc
30 June 2009
 



SerVision Plc

("SerVision" or "the Company")

FINAL RESULTS

SerVision (AIM:SEV), the AIM listed leading developer and manufacturer of digital security systems, announces its full year audited results for the financial year ended 31 December 2008.

Highlights:

Turnover for the period increased by 15.5% to $4.732m (2007: $4.097m)

Gross profit for the period increased by 16% to $2.227m (2007: $1.195m)

Loss for the period was reduced by 28% to $1.064m (2007: $1.497m)

Breakeven point reached in the final six months of the period

Commenting on the results Gidon Tahan, chairman and chief executive, said: "I am extremely pleased with the progress we have made since our last final results. To have reached breakeven point in the midst of a global recession is an achievement I am very proud of. Thank you to the employees of SerVision for all their hard work in making this possible."

The full text of the Annual Report and Audited Financial Statements including the notes to the Financial Statements for the financial year ended 31 December 2008 will be sent to shareholders on 30 June 2009 and are available on the Company's website.

Chairman's Statement

I am pleased to announce SerVision's condensed group financial statements for the twelve months ending 31 December 2008. The period under review was one of continued worldwide financial turmoil and SerVision has not been immune from feeling the effects of this crisis. Despite this however I am delighted to announce that we saw moderate revenue growth compared with 2007.

Additionally, after seven years of operating and investing heavily in research and development, the company reached break even point in last six months of 2008 making the yearly loss slightly less than the loss announced in the first six months of the year. Achieving this milestone despite the worldwide economic instability is extremely encouraging and I thank the shareholders for their continued support through the research and development phase.

Operating Review

In the period we have widened our distribution network and territorial reach by signing new distribution agreements. We have recently announced major distribution contracts in China and India and we hope to announce further agreements in the coming months. This expansion of our customer base and the growth in sales to existing customers has translated into a pleasing growth in revenue. 

Research and Development

The Company's research and development team has finished developing an eight channel mobile system which will enable vehicle operators to use a more efficient cost effective solution in larger vehicles doubling the number of channels in each system installed. If internal timetables are met, and market demand looks promising, this new technology could be commericialised in the fourth quarter of the current financial year. 

In addition, the Company is about to release to the market its new light weight (75 grams) one channel system that can be deployed on individuals such as policemen and soldiers. This product has the potential to reach customers who would not previously have had a need for SerVision's products. The widening of our target market we hope will contribute to the Company's future growth. Distribution of this new product is expected for both the military and civil markets through cooperation with cellular providers and could occur as early as the fourth quarter of the current financial year.

Financial Review

As mentioned above in the last six months of the period the company reached break even point for the first time since established.

Turnover for the annual period increased 15.5% to US$4.73m compared to US$4.09m for the same period last year. Losses of US$1.06m (2007 loss: US$1.48m) were well below the same period in 2007 representing a reduction of 28%. 

SerVision is tendering for a greater number of large contracts than in previous years and maintains a healthy indicative order book for 2009.

I am pleased that SerVision continues to make steady progress towards achieving its goals and we look forward to the future with cautious optimism. On a personal note, I would like to thank all of our dedicated staff for their loyalty and hard work throughout the period that was essential for our significant progress and growth.

Gidon Tahan

Chairman and Chief Executive Officer 

Results

The Directors present the annual report together with the financial statements and auditors report for the year ended 31 December 2008.

The Company was incorporated in the UK but its principal place of business is in Israel.

PRINCIPAL ACTIVITIES AND REVIEW OF BUSINESS

The Company's principal activity is the development and sale of video surveillance equipment. The results for the Group can be found on page 8.

ACCOUNTS PRODUCTION

The financial statements for the year ended 31 December 2008 have been prepared in accordance with International Financial Reporting Standards.

DIVIDENDS 

The Directors do not propose a final dividend (2007: £nil).

GOING CONCERN

After making enquiries, the Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the accounts.

CONSOLIDATED INCOME STATEMENT

 
 
 
 
2008
2007
 
 
 
 
 
$’000
$’000
 
 
 
 
 
 
REVENUE
 
4,732
4,097
 
 
 
 
Cost of sales
 
(2,505)
(2,182)
 
 
 
 
--------------
-------------
GROSS PROFIT
 
 
 
2,227
1,915
 
 
 
 
 
 
Administrative expenses
 
 
 
(2,040)
(1,821)
Depreciation and amortisation
 
 
 
(1,142)
(1,327)
Exchange rate differences
 
 
 
98
(117)
 
 
 
 
---------------
-------------
OPERATING LOSS
 
 
 
(857)
(1,350)
 
 
 
 
 
 
Net finance expenditure
 
 
(207)
(129)
 
 
 
---------------
-------------
LOSS ON ORDINARY
 
 
 
 
 ACTIVITIES BEFORE TAXATION
 
 
(1,064)
(1,479)
 
 
 
 
 
Tax on ordinary activities
 
 
-
-
 
 
 
---------------
-------------
LOSS FOR THE PERIOD
 
 
(1,064)
(1,479)
 
 
 
========
======
 
 
 
 
 
LOSS PER SHARE
 
 
 
 
 
 
 
 
 
Basic and diluted
 
(4.12c)
(6.21c)
 
 
 
======
======
 

  CONSOLIDATED BALANCE SHEET

 
 
2008
2007
 
 
$’000
$’000
ASSETS
 
 
 
Non-current assets
 
 
 
Intangible assets
 
3,860
3,456
Property, plant and equipment
 
66
96
 
 
----------------
--------------
 
 
3,926
3,552
 
 
----------------
--------------
Current assets
 
 
 
Inventories
 
563
557
Trade and other receivables
 
1,455
1,010
Cash and cash equivalents
 
136
381
 
 
----------------
--------------
 
 
2,154
1,948
 
 
----------------
--------------
 
 
6,080
5,500
 
========
========
EQUITY
 
 
 
Capital and reserves attributable to the Company’s
 
 
 
 equity shareholders
 
 
 
Called up share capital
 
556
467
Share premium account
 
9,776
8,075
Merger reserve
 
1,979
1,979
Retained earnings and translation reserves
 
(10,060)
(8,566)
 
 
----------------
--------------
TOTAL EQUITY
2,251
1,955
 
 
========
========
LIABILITIES
 
 
 
Non-current liabilities
 
 
 
Bank loans
 
428
415
Loan from the office of the chief scientist
 
882
865
Post employment benefits
 
194
256
 
-----------------
-----------------
 
 
1,504
 1,536
 
 
-----------------
-----------------
 
 
 
 
Current liabilities
 
 
 
Bank loans and overdrafts
 
558
814
Loan from the office of the chief scientist
 
109
104
Trade and other payables
 
1,658
1,091
 
 
-----------------
---------------
 
 
2,325
2,009
 
 
-----------------
---------------
TOTAL LIABILITIES
 
3,829
3,545
 
 
-------------------
-----------------
TOTAL EQUITY AND LIABILITIES
 
6,080
5,500
 
 
=========
========

  CONSOLIDATED CASH FLOW STATEMENT

 

 
 
2008
2007
 
 
$’000
$’000
 
 
 
 
Cash flows from operating activities
 
 
 
Loss before taxation
 
(1,064)
(1,479)
Adjustments for:
 
 
 
Net finance expense
 
207
129
Net interest paid
 
(207)
(129)
Depreciation and amortisation
 
1,140
1,327
Loss on disposal of fixed assets
 
9
--
Movement in trade and other receivables
 
(305)
(21)
Movement in inventories
 
(6)
(234)
Movement in grant from the office of the chief scientist
 
22
52
Movement in post retirement benefits
 
(62)
108
Movement in trade and other payables
 
567
(16)
 
 
---------------
---------------
Net cash generated from operating activities
 
301
(263)
 
 
 
 
Cash flow from investing activities
 
 
 
Purchase of property, plant and equipment and intangibles
 
(1,523)
(1,512)
 
 
-----------------
---------------
Net cash used in investing activities
 
(1,523)
(1,512)
 
 
-----------------
---------------
Cash flows from financing activities
 
 
 
Issue of shares
 
1,650
1,012
Net loans undertaken less repayments
 
127
166
 
 
-----------------
---------------
Cash generated from financing activities
 
1,777
1,178
 
 
-----------------
--------------
 
 
 
 
Cash and cash equivalents at beginning of period
 
(87)
77
Net cash generated from all activities
 
555
(597)
Non-cash movement arising on foreign currency translation
 
(430)
433
 
 
----------------
--------------
Cash and cash equivalents at end of period
 
38
(87)
 
 
=======
======
Cash and cash equivalents comprise
 
 
 
Cash (excluding overdrafts) and cash equivalents
 
136
381
Overdrafts
 
(98)
(468)
 
 
-----------------
--------------
 
 
38
(87)
 
 
========
======

  CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

 
 
Share
Share
Merger
Retained
Translation
 
 
 
Capital
Premium
Reserve
Earnings
Reserve
Total
 
 
$’000
$’000
$’000
$’000
$’000
$’000
 
 
 
 
 
 
 
 
At 1 January 2007
 
429
7,101
1,979
(7,674)
154
1,989
 
 
 
 
 
 
 
 
Total recognised income
 
 
 
 
 
 
 
and expenses
 
-
-
-
(1,479)
-
(1,479)
Exchange rate differences
 
-
-
-
-
433
433
Issue of shares (net of costs)
38
974
-
-
-
1,012
 
 
-----------
------------
-------------
-------------
------------
------------
At 31 December 2007
 
467
8,075
1,979
(9,153)
587
1,955
 
 
 
 
 
 
 
 
Total recognised income
 
 
 
 
 
 
 
and expenses
 
-
-
-
(1,064)
-
(1,064)
Exchange rate differences
 
-
-
-
-
(430)
(430)
Issue of shares (net of costs)
89
1,701
-
-
-
1,790
 
 
-----------
------------
-----------
--------------
------------
--------------
At 31 December 2008
 
556
9,776
1,979
(10,217)
157
2,251
 
 
=====
=====
=====
=======
======
======
 
 
 
 
 
 
 
 

  NOTES TO THE FINANCIAL STATEMENTS

 

1. ACCOUNTING POLICIES

Basis of Preparation

These financial statements have been prepared in accordance with those IFRS standards and IFRIC interpretations issued and effective or issued and early adopted as at the time of preparing these statements (June 2009). The policies set out below have been consistently applied to all the years presented. 

These consolidated financial statements have been prepared under the historical cost convention.

No separate profit and loss account is presented for the parent company as provided by Section 230, Companies Act 1985.

Basis of Consolidation

Group accounts consolidate the accounts of the company and its subsidiary undertakings made up to 31 December 2008.

All intercompany balances and transactions have been eliminated in full. Subsidiary undertakings are accounted for from the effective date of acquisition until the effective date of disposal.

Going concern

Since the year-end, the group has continued to suffer losses, impacting on the cashflow position. The directors are currently negotiating further financing and are continuing to develop the group's products. 

Subject to the successful completion of these events, and on this basis, the directors consider that it is appropriate to prepare the financial statements on the going concern basis. If additional financing by whatever means is not secured in the next twelve months, then it is unlikely that the company will be able to continue in its present form.

The ability of the group to continue as a going concern for the foreseeable future, is dependent on the following factors:

Securing further financing either in the form of debt or equity.

On the continued support in the form of grants receivable from the Office of the Chief Scientist.

Achieving its forecast results for the period to 30 June 2010 which the directors believe are achievable.

Continued support from the banks in terms of the loans/overdrafts currently in place.

If further financing does not occur then the group is able to scale down their operations to ensure that expenses are met.

Based on the above factors, the directors consider it appropriate to prepare the financial statements on the going concern basis. The financial statements do not include any adjustments that would be necessary should this basis not be appropriate.

Segment reporting 

The Company has one business segment that of developing and selling video surveillance equipment. Segmental reporting is produced on a geographical basis by place of sale.

Revenue recognition

Revenue comprises the fair value of the sale of goods and services, net of value added tax, rebates and discounts.

Grants from the Office of the Chief Scientist

Prior grants received from the Office of the Chief Scientist ("OCS") to finance research and development costs of the subsidiary were presented as a long-term loan at the date of receipt. The loan is repaid by the payment of royalties to the Chief Scientist and is calculated as a percentage of sales of the subsidiary.

The subsidiary is required to pay to the OCS under the subsidiary's research and development agreements with the OCS and pursuant to applicable laws royalties at the rate of 3-5% of sales for products developed with funds provided by the OCS, up to an amount equal to 100% of the OCS research and development grants received plus interest based on the 12-month LIBOR rate applicable to dollar deposits.

The subsidiary is obligated to repay the Israeli Government for the grants received only to the extent that there are sales for the funded products.

Research and development

Expenditure for research activities are recognised as an expense in the period in which it is incurred.

Expenditure for the development activities of technology used in the production of systems sold by the Company, are capitalised and presented as an asset in the balance sheets only if all of the following conditions are met:

Development costs of the technology are identifiable and separable.

It is probable that the developed technology will generate future economic benefits.

The development costs of the technology can be measured reliably.

 

Development costs meeting these criteria are capitalised and amortised on a straight-line basis over their useful lives once the related technology is available for use.

2. BUSINESS SEGMENT ANALYSIS

 
 
UK
 
Europe
Middle East
North America
Rest of the world
 
Total
Year ended 31 December 2007:
$’000
$’000
$’000
$’000
$’000
$’000
 
 
 
 
 
 
 
 
 
Revenue
 
 
 
 
 
 
 
External sales
-
2,037
359
509
1,192
4,097
 
 
=====
=====
=====
=======
======
======
 
Loss
 
 
 
 
 
 
 
Segment operating loss
(130)
(458)
(389)
(112)
(261)
(1,350)
 
Net finance costs
 
 
 
 
 
(129)
 
 
 
 
 
 
 
-------------
 
Loss before taxation
 
 
 
 
 
(1,479)
 
 
 
 
 
 
 
=======
 
Capital expenditure
-
-
1,512
-
-
1,512
 
 
=====
=====
=====
=======
======
======
 
Depreciation and amortisation
-
-
1,327
-
-
1,327
 
 
=====
=====
=====
=======
======
======
 
At 31 December 2007:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assets and liabilities
 
 
 
 
 
 
 
Segment assets
-
18
4,332
262
507
5,119
 
Segment liabilities
(49)
(1)
(3,069)
(23)
(22)
(3,164)
 
 
----------
-----------
------------
------------
-------------
-------------
 
Net (liabilities)/assets
(49)
17
1,263
239
485
1,955
 
 
=====
=====
======
======
======
======
 
Year ended 31 December 2008:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
 
 
 
 
 
 
 
External sales
-
2,044
561
833
1,294
4,732
 
 
=====
=====
=====
=======
======
======
 
Loss
 
 
 
 
 
 
 
Segment operating loss
(149)
(305)
(84)
(124)
(195)
(857)
 
Net finance costs
 
 
 
 
 
(207)
 
 
 
 
 
 
 
-------------
 
Loss before taxation
 
 
 
 
 
(1,064)
 
 
 
 
 
 
 
=======
 
Capital expenditure
-
-
1,523
-
-
1,523
 
 
=====
=====
=====
=======
======
======
 
Depreciation and amortisation
-
-
1,140
-
-
1,140
 
 
=====
=====
=====
=======
======
======
 
At 31 December 2008:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assets and liabilities
 
 
 
 
 
 
 
Segment assets
140
134
4,617
349
704
5,944
 
Segment liabilities
(112)
(17)
(3,499)
(51)
(14)
(3,693)
 
 
------------
-----------
------------
------------
---------------
---------------
 
Net (liabilities)/assets
28
117
1,118
298
690
2,251
 
 
======
=====
======
======
=======
=======

3
COST OF SALES
 
2008
2007
 
 
 
$’000
$’000
 
 
 
 
 
 
Materials and parts
 
1,966
1,606
 
Employee benefit expense
 
325
339
 
Sub contractors
 
-
56
 
Other costs
 
214
181
 
 
 
------------
-----------
 
 
 
2,505
2,182
 
 
 
======
=====

4.
CALLED UP SHARE CAPITAL
 
 
2008
2007
 
 
 
 
$’000
$’000
 
Authorised:
 
The authorised share capital consists of 300,000,000 ordinary shares of £0.01 each and 2,000,000 deferred shares of £0.001 each.
 
Allotted, called up and fully paid:
 
 
 
 
29,881,490 (2007: 24,773,637) ordinary shares of £0.01 each
1,550
1,461
 
 384,615 deferred shares of £0.001 each
 
2
2
 
 
 
 
---------------
---------------
 
 
 
 
1,552
1,463
 
 
 
 
=======
=======

5
TRADE AND OTHER PAYABLES
2008
2007
 
 
Group
Company
Group
Company
 
 
$’000
$’000
$’000
$’000
 
 
 
 
 
 
 
Trade payables
423
-
490
-
 
Other taxes and social security
911
-
369
-
 
Other payables
167
-
144
-
 
Accruals and deferred income
157
112
88
49
 
 
--------------
---------------
-----------------
---------------
 
 
1,658
112
1,091
49
 
 
=======
=======
========
=======
 
 
 
 
 
 

6
BANK LOANS AND OVERDRAFTS
 
 
2008
2007
 
 
 
 
$’000
$’000
 
Group
 
 
 
 
 
 
 
 
 
 
 
Bank overdraft
 
 
98
468
 
Bank loans: amounts due within one year
 
 
460
346
 
 
 
 
---------------
---------------
 
Current liability
 
 
558
814
 
Bank loans: amounts due within two to five years
 
428
415
 
 
 
 
--------------
---------------
 
Total bank loans and overdrafts
 
 
986
1,229
 
 
 
 
=======
=======
 
 
 
 
 
 

7. LOSS PER SHARE

The loss per share of 4.12c (2007: loss 6.21c) has been calculated on the weighted average number of shares in issue during the year namely 25,865,120 (2007: 23,831,197) and losses of US$1,064,500 (2007: US$1,478,953).


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR GUGDLGXXGGCG

Related Shares:

Servision PLC
FTSE 100 Latest
Value8,275.66
Change0.00